224 related articles for article (PubMed ID: 33113455)
1. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
Liu J; Li X; Yang S; Mou J; Lu H
Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
[TBL] [Abstract][Full Text] [Related]
4. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
Tai J; Park J; Han M; Kim TH
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
[TBL] [Abstract][Full Text] [Related]
6. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
Zhang JZ; Wu ZH; Cheng Q
Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
[TBL] [Abstract][Full Text] [Related]
7. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
[TBL] [Abstract][Full Text] [Related]
8. Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.
Yu G; Hsu WL; Coghill AE; Yu KJ; Wang CP; Lou PJ; Liu Z; Jones K; Vogt A; Wang M; Mbulaiteye SM; Chen HH; Boland J; Yeager M; Diehl SR; Chen CJ; Hildesheim A; Goldstein AM
Sci Rep; 2019 Jul; 9(1):9916. PubMed ID: 31289279
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis.
Xu Y; Huang X; Ye W; Zhang Y; Li C; Bai P; Lin Z; Chen C
Cancer Cell Int; 2020; 20():408. PubMed ID: 32863767
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
[TBL] [Abstract][Full Text] [Related]
12. Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.
Wang Y; Li M; Guo Y; Huang H; Dong X; Sun Y; Liu J
Aging (Albany NY); 2021 Sep; 13(18):22176-22187. PubMed ID: 34544905
[TBL] [Abstract][Full Text] [Related]
13. The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data.
Ge Y; He Z; Xiang Y; Wang D; Yang Y; Qiu J; Zhou Y
Mol Biol Rep; 2019 Jun; 46(3):2829-2840. PubMed ID: 30830589
[TBL] [Abstract][Full Text] [Related]
14. Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis.
Pan X; Liu JH
Bioengineered; 2021 Dec; 12(1):3647-3661. PubMed ID: 34261404
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients.
Wu ZH; Zhou T; Sun HY
Medicine (Baltimore); 2020 Jun; 99(24):e20682. PubMed ID: 32541515
[TBL] [Abstract][Full Text] [Related]
16. Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma.
Wang B; Wang W; Wang H; Liu W
Bull Exp Biol Med; 2021 Mar; 170(5):658-664. PubMed ID: 33788105
[TBL] [Abstract][Full Text] [Related]
17. Integrated miRNA-mRNA analysis of Epstein-Barr virus-positive nasopharyngeal carcinoma.
Zhu LH; Miao XT; Wang NY
Genet Mol Res; 2015 Jun; 14(2):6028-36. PubMed ID: 26125802
[TBL] [Abstract][Full Text] [Related]
18. [Immunocyte infiltration characteristics of gene expression profile in nasopharyngeal carcinoma and clinical significance].
Yang Y; Zhang P; Zhang H; Lu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1069-1075. PubMed ID: 33325359
[TBL] [Abstract][Full Text] [Related]
19. Explore the shared molecular mechanism between dermatomyositis and nasopharyngeal cancer by bioinformatic analysis.
Zhong X; Shang J; Zhang R; Zhang X; Yu L; Niu H; Duan X
PLoS One; 2024; 19(5):e0296034. PubMed ID: 38753689
[TBL] [Abstract][Full Text] [Related]
20. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
